New website simplifies access for biotech and biopharma users

ProBioGen has launched its redesigned website, offering biotech and biopharma professionals streamlined access to its expanded services and proprietary technologies. The updated platform delivers an intuitive user experience, enabling faster navigation and easier access to essential information.

The enhanced website provides a seamless way to explore ProBioGen’s comprehensive portfolio, which includes cell line development, cell banking, process and full analytical development, GMP manufacturing, and advanced solutions for proteins, viral vectors, and vaccines. It also highlights proprietary technologies like GlymaxX® and DirectedLuck®, designed to improve efficacy, boost productivity, and accelerate time to clinic.

With a clearer structure, the new website makes it easier than ever to find relevant content. Dedicated sections for CDMO services, technologies, news, resources, and company information ensure visitors can quickly access what they need. The site also features detailed descriptions of ProBioGen’s portfolio, along with scientific studies, white papers, and industry updates, providing comprehensive insights to help users make informed decisions and advance their projects.

Designed for convenience, the fully responsive and interactive interface allows seamless browsing across all devices. Whether on a desktop or mobile, users can efficiently navigate the platform and access key information anytime, anywhere.

“Our updated website reflects ProBioGen’s commitment to innovation and customer collaboration,” said Dr Gabriele Schneider, Chief Business Officer at ProBioGen. “By prioritising clarity and ease of use, we empower visitors to make informed decisions, streamline project planning, and accelerate progress in next-generation therapies.”

More information online